Funding available for testing innovative SBIRT/P methods for alcohol, tobacco, and drug use in adults with health disparities.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | May 7, 2027 (Closing date)
Funding Amounts: No budget limit; requests must reflect project needs; up to 5 years; no cost sharing required
Summary: Supports clinical trials testing innovative SBIRT/P implementation approaches for substance use and misuse in adults experiencing health disparities.
Key Information: Projects must prospectively test SBIRT/P in NIH-designated populations experiencing health disparities.
The NIH Office of Disease Prevention and participating Institutes, Centers, and Offices support R01 research testing innovative approaches to implementing Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P). The program focuses on alcohol, tobacco, and other drug use and misuse in adult NIH-designated populations experiencing health disparities. SBIRT/P combines screening, brief conversations about harmful substance use, and referrals to treatment or preventive services.
Research should address implementation barriers and improve access, uptake, effectiveness, quality, or sustainability. Relevant approaches include adapting SBIRT/P for different populations, scaling implementation in nontraditional settings, improving referral follow-through, addressing multiple substances or co-occurring conditions, and changing organizational systems. Robust engagement with healthcare and community partners is strongly encouraged.